Lidaprim forte

Quick links

Choose a section

Quick links to important sections

Advertisements

Lidaprim forte

Advertisements
Advertisements

Overview of Lidaprim forte

Quick Facts

Property Description
Active ingredient Sulfametrole, Trimethoprim
Form Tablet (Oral)
Pharmacological class Antibiotic (Antimicrobial)
Common use Systemic bacterial infections
Origin Synthetic
Type Fixed-dose combination

Lidaprim forte: A Fixed-Dose Combination Antibiotic

Lidaprim forte is a synthetic antibacterial medicine classified as a fixed-dose combination antibiotic, engineered to fight susceptible bacterial infections. It belongs to the pharmacological class of antimicrobials and is structurally defined by the strategic pairing of a sulfonamide (Sulfametrole) and a diaminopyrimidine (Trimethoprim). It is typically administered via the oral route as a tablet (Oral solid dosage form) for use as a systemic anti-infective agent. Lidaprim forte is a specific trade name for this formulation, which is therapeutically analogous to other co-trimoxazole preparations but utilizes Sulfametrole instead of the more common sulfamethoxazole component.

What is the Composition and Unique Synergistic Design?

The composition of Lidaprim forte features the active ingredients: Sulfametrole and Trimethoprim. This unique synergistic composition is specifically designed to create a "sequential block" in the bacterial process of generating folic acid, which is essential for the bacteria to synthesize their DNA and RNA. This mechanism results in a bactericidal effect, meaning it kills the target bacteria. The "forte" designation is a distinguishing characteristic, indicating this formulation contains a higher concentration of these active ingredients compared to standard strengths, targeting specific needs in the adult patient group.

General Purpose: Targeting Bacterial Infections

The general purpose of Lidaprim forte is to provide effective systematic defense against a range of susceptible bacterial infections throughout the body. Due to the combined action against pathogens, this medication is used to resolve infections, focusing on general indications like those affecting the urinary tract and certain respiratory tract infections. The drug’s synthetic antibacterial nature and dual mechanism provide an established therapeutic tool for managing infections where this level of targeted efficacy is required.

Advertisements

What side effects are possible with Lidaprim forte?

Possible side effects and safety information

The official safety profile for Lidaprim forte (Sulfametrole/Trimethoprim) classifies potential adverse reactions based on their frequency and the body system affected, strictly following regulatory documentation standards.

Frequency-Classified Adverse Reactions

Adverse reactions are formally grouped by regulatory frequency criteria:

Classification Examples of Documented Reactions
Common (1% to 10%) Nausea, Diarrhea, Headache
Uncommon (0.1% to 1%) Vomiting, Loss of Appetite
Frequency Not Reported Severe blood disorders, Serious Skin Reactions

Systemic Safety and Serious Reactions

Potential effects are documented across several System-Organ Classes, including Gastrointestinal Disorders, Skin and Subcutaneous Tissue Disorders, Blood and Lymphatic System Disorders (e.g., Agranulocytosis, Aplastic Anemia), and Hepatobiliary Disorders (e.g., Hepatic Necrosis). The safety profile explicitly notes the risk for Serious Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Population and Duration-Related Safety

Regulatory documents include specific constraints for certain populations. The medicine is contraindicated in infants under 2 months of age and in patients with marked hepatic damage or severe renal insufficiency where monitoring is not feasible. Older adults are cited as having a potentially higher risk for serious skin reactions and blood disorders. Time-related safety patterns are noted: the highest risk period for SCARs is generally within the initial weeks of treatment, while blood count monitoring may be necessary with long-term use.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Suspected overexposure to Lidaprim forte requires immediate action as mandated by regulatory authorities. Seek immediate medical attention or contact emergency services immediately if an overdose is known or suspected.

Regulatory documents outline that acute overdosage is officially documented to manifest with symptoms including anorexia and vomiting. Systemic signs listed in labeling include fever and neurological changes such as confusion or, in severe cases, loss of consciousness. Furthermore, acute presentations may involve jaundice (a potential indication of hepatic effects) and hematuria (blood in the urine).

Chronic, high-dose overexposure is formally associated with the development of megaloblastic anaemia.

Official labeling describes required supportive measures in a clinical setting, which may include gastric lavage and the administration of activated charcoal to reduce absorption. General supportive measures and symptomatic treatment are the documented foundation of care. Calcium folinate is the described intervention for the hematological effects of the Trimethoprim component.

Special attention is required for patients with severely impaired renal function, as official labeling notes an increased half-life for both active components in this group, which may intensify toxicity.

Advertisements

Therapeutic Uses of Lidaprim forte

What Lidaprim forte Treats: Main Uses and Benefits

Lidaprim forte is commonly used to address the symptomatic discomfort and infection associated with bacterial urinary tract conditions, addressing conditions that range from typical urinary tract discomfort to more complex infections. The medication is used for managing conditions involving symptomatic discomfort, which may provide symptomatic relief that helps patients cope with difficult episodes, such as painful urination (dysuria) and urgency. The medication is considered relevant in clinical settings that involve acute or unstable symptom patterns.

This antibiotic is generally applied in contexts that require broad-spectrum support for acute bacterial issues, including acute exacerbations of chronic bronchitis, certain types of pneumonia, and specific gastrointestinal infections like traveler’s diarrhea. For high-risk individuals, it is also used as part of symptomatic management to help prevent the onset of certain severe infections, such as Pneumocystis jirovecii pneumonia.

“This medication is relevant for easing the overall symptom load and supports the patient during difficult acute episodes, in situations where symptoms become more noticeable.”

Quick Fact: Therapeutic Context for Acute Episodes

Symptom Domain General Therapeutic Benefit
Painful Urination (Dysuria) Supports patients during episodes of heightened discomfort.
Fever and Systemic Symptoms Contributes to easing the overall symptom load.
Recurrent Infections Supports patients during episodes of heightened discomfort.
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Lidaprim forte

This section outlines the population eligibility rules for Lidaprim forte (Sulfametrole/Trimethoprim) based strictly on authoritative governmental regulatory documents.

Eligibility Scope

Category Eligibility Status
Populations Allowed Adults and Adolescents (typically age 12 and older) without contraindications.
Populations Contraindicated Patients with known hypersensitivity to trimethoprim or sulfonamides.
Infants under 2 months of age (absolute contraindication).

Condition and Organ Restrictions

Use is strictly contraindicated for individuals with pre-existing conditions such as severe megaloblastic anemia due to folate deficiency, severe hepatic damage, or severe renal insufficiency when drug level monitoring cannot be performed. The medicine is also not recommended for patients with acute hepatic porphyria.

Age and Reproductive Status

  • Pediatric Use: Use is approved for children 2 months of age and older, but caution is necessary.
  • Older Adults: Use requires caution due to a higher likelihood of underlying renal or hepatic impairment.
  • Pregnancy: Contraindicated in the first trimester and not recommended in the third trimester.
  • Lactation: Not recommended for nursing mothers, especially if the infant is premature or has specific health risks.
Advertisements

What should I know about interactions with other medicines?

Lidaprim forte Interactions with other Medicines and Products

This section details officially documented interaction patterns for Lidaprim forte (Sulfametrole/Trimethoprim), derived strictly from government regulatory information.

Formal Regulatory Constraints

Classification Interacting Substance Regulatory Implication
Contraindicated Dofetilide Combination is formally prohibited due to serious risk.
Use with Caution Leucovorin (Folinic Acid) Avoid concurrent use when treating Pneumocystis jirovecii pneumonia due to documented increased mortality risk.

Clinically Significant Interaction Groups

Co-administration with Lidaprim forte may result in altered plasma concentrations or potentiated effects for several medications:

  • Exposure-Altering Drugs: Medications like Warfarin, Phenytoin, and Digoxin may have increased plasma levels or prolonged effects due to reduced clearance, necessitating careful monitoring.
  • Metabolic and Transporter Interference: The combination can potentiate effects of drugs metabolized by CYP2C8/2C9 (e.g., certain oral hypoglycemics) and interact with OCT2 substrates (e.g., Metformin).
  • Pharmacodynamic Additive Effects: Combining with ACE Inhibitors, ARBs, or potassium-sparing diuretics (e.g., Spironolactone) increases the official risk of hyperkalemia (high blood potassium).

Population-Specific Notes

The risk of elevated Digoxin levels is noted to be greater especially in elderly patients. Additionally, severely impaired renal function affects the clearance and increases the half-lives of the antibiotic's components.

Advertisements

Mechanism of Action

Sequential Blockade of Bacterial Folate Metabolism

The drug's mechanism centers on the simultaneous, sequential inhibition of two critical enzymes—dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR)—within the bacterial folate synthesis pathway. This dual target action on two consecutive metabolic steps creates a double blockade, interrupting a process required for microbial replication.

Synergistic Inhibition of DNA and Protein Synthesis

By halting the creation of active Tetrahydrofolic acid (THF), the mechanism starves the bacterial cell of precursors needed for constructing DNA and RNA. The combination's synergistic effect—significantly greater than the sum of its parts—forces the bacterial cell from a growth-inhibited state to rapid cell death, which is the foundational physiological consequence of its mechanism.

Mechanism Limitations via Target Enzyme Adaptation

The drug's effectiveness is constrained by the pathogen's ability to develop resistance, primarily through mutations in the target enzymes (DHPS or DHFR) that reduce the drug's binding affinity. This adaptation functionally limits the drug's binding affinity, preventing complete disruption of the metabolic cascade in resistant organisms.

Advertisements

Dosage and Administration Information

Lidaprim forte is a fixed-dose combination antibiotic administered primarily via the oral route as a tablet, though the intravenous (IV) infusion route is an alternative for use when oral intake is not feasible. The oral form is taken with a full glass of water, and it is recommended to maintain adequate hydration throughout the course of treatment.

The standard adult dosing regimen typically involves taking the Double Strength (DS) equivalent twice daily (every 12 hours). However, the frequency can be adjusted by prescribers, ranging from once daily for long-term prophylaxis to three or four times daily for treating severe systemic infections. The duration of therapy is short-term and fixed, ranging from as few as five days to an extended course of up to twenty-one days, depending on the specific use context.

Administration involves specific considerations, especially regarding renal function. The usual dosage is halved for patients with moderate renal impairment, defined by a Creatinine Clearance between 15 and 30 mL/min. If the IV route is utilized, the solution must be diluted prior to use and administered as a slow infusion over 60 to 90 minutes; rapid or bolus injection is not indicated. This structured approach ensures use is consistent with the pharmacological design of the medication.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Lidaprim forte

Evidence for Use in Urinary Tract Infections (UTIs)

Research has examined this antibiotic combination for Urinary Tract Infections (UTIs), which are conditions associated with acute or disruptive episodes and outcomes related to physical discomfort. Randomized Controlled Trials (RCTs) and non-comparative clinical studies was evaluated in cohorts of adults and children to assess how this combination was observed in patients with both uncomplicated and complicated UTIs.

The studies monitored several outcomes related to physical discomfort, including the measurement of change in patient-reported symptoms like painful urination, as well as measurements related to microbiological outcome. While this combination was studied for UTIs, findings describe patterns observed in the studies predominantly within the context of the larger co-trimoxazole class of antibiotics. Evidence is limited when looking only at contemporary, large-scale RCTs that focus specifically on the Sulfametrole/Trimethoprim formulation used in Lidaprim forte.

Evidence for Use in Preventing and Treating Pneumocystis jirovecii Pneumonia (PJP)

The use of this antibiotic class for both the prevention (prophylaxis) and treatment of Pneumocystis jirovecii pneumonia (PJP) was evaluated in extensive research. Systematic reviews and Randomized Controlled Trials (RCTs) were evaluated in highly specific cohorts of immunocompromised patients, most notably HIV-infected adults and children. Studies explored outcomes reflecting daily functioning or activity level and monitored mortality rates to describe patterns in patients observed in long-term PJP prevention studies. These findings contribute to understanding symptom patterns and are data show patterns related to the evidence landscape for this condition. The high-level evidence is limited specifically to the therapeutic class (co-trimoxazole), with much of the foundational evidence pertaining to the analogous Sulfamethoxazole/Trimethoprim combination.

What is Still Uncertain About the Research for Lidaprim forte

The primary limitation is the scarcity of contemporary evidence specifically for the Sulfametrole/Trimethoprim combination, with much of the foundational evidence being older. Comparative evidence is lacking to directly measure this formulation against other commonly used treatments. Furthermore, data for certain groups remain insufficient for individuals who may have comorbid conditions. Research is ongoing to provide further context and address these evidence gaps.

Key Studies & References Pneumocystis Pneumonia: Adult and Adolescent Opportunistic Infections - NIH Clinical Info Guidelines (Used to establish the standard of care and the evidence base for co-trimoxazole prophylaxis and treatment in immunocompromised patients)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Lidaprim forte (FAQ)

Q: How quickly does Lidaprim forte start working?

A: The active ingredients in the co-trimoxazole class of medicines are typically absorbed rapidly following oral administration. Official drug information does not usually specify the exact time when a patient should notice clinical relief or feel the full effect of the medicine.

Q: What happens if I miss a dose of Lidaprim forte?

A: Regulatory documents indicate a structured approach for handling missed doses. If a patient is following a prescribed schedule, they are typically instructed not to take two doses simultaneously to make up for a missed one.

Q: How long after stopping Lidaprim forte does it stay in your system?

A: The half-life (the time it takes for half the drug to be eliminated) for the main components is approximately 7 to 10 hours in people with normal kidney function. Full clearance from the body typically occurs after a period equivalent to several half-lives, but this duration can vary between individuals.

Q: Can children or teenagers use Lidaprim forte?

A: Official labeling states that this class of antibiotic is contraindicated (should not be used) in infants under two months of age. It is indicated for use in pediatric patients aged two months and older for certain conditions and requires careful consideration and professional guidance for appropriate use.

Q: What is the purpose of the 'forte' in the name Lidaprim forte?

A: The 'forte' or Double Strength (DS) designation is used to indicate that the tablet contains a higher concentration of the active ingredients than a standard-strength tablet. This formulation is often equivalent to the 160 mg trimethoprim and 800 mg sulfamethoxazole found in analogous DS products.

Q: Can you get Lidaprim forte over the counter?

A: No. According to regulatory status, this medication is classified as a prescription-only antibiotic and is not available for purchase without a valid prescription.

Q: Can Lidaprim forte affect my sleep?

A: While not listed as a common reaction, the list of reported side effects does include nervous system disorders, such as insomnia (difficulty sleeping). The appearance of any unexpected changes or side effects should be discussed with a healthcare professional.

Q: What is the difference between Lidaprim and Lidaprim forte?

A: Lidaprim (Standard Strength) generally contains half the dose of the active ingredients found in Lidaprim forte (Double Strength). The 'forte' designation is used to differentiate the higher-dose formulation for specific needs.

Q: Is the use of Lidaprim forte appropriate for individuals with kidney problems?

A: Official guidelines state that the medicine is not recommended for individuals with severe kidney impairment. The labeling indicates that moderate kidney impairment typically necessitates an adjustment to the dose regimen due to altered drug clearance.

Q: Are there any major food interactions with Lidaprim forte?

A: Official regulatory labeling does not identify major food interactions that would significantly impact the absorption of the drug. However, specific regulatory warnings exist regarding high-potassium foods due to the drug's known effect on potassium levels.

Q: Is Lidaprim forte a broad-spectrum medicine?

A: This medicine is indicated for treating infections caused by a range of susceptible strains of both Gram-positive and Gram-negative bacteria. This range of activity aligns with its classification as a broad-spectrum agent within its specific class of antibiotics.

Q: Why do doctors prescribe Lidaprim forte instead of other medicines?

A: Lidaprim forte is typically prescribed when an infection is known or suspected to be caused by a bacterial strain susceptible to this specific drug combination. The medicine's dual action is known to create a powerful, synergistic bactericidal effect, making it an established treatment for certain infections, such as Pneumocystis pneumonia.

Q: Can I drink alcohol while taking Lidaprim forte?

A: Official patient counseling information advises against the consumption of alcohol while using this medicine. This is because the components can interfere with the breakdown of alcohol, potentially leading to side effects such as flushing, headache, nausea, and vomiting (a disulfiram-like reaction).

Q: What should I do if I get a rash from Lidaprim forte?

A: Official warnings state that due to the risk of serious skin reactions, the drug should be discontinued at the first sign of a skin rash or any other adverse reaction. A healthcare professional should be contacted immediately, as regulatory warnings emphasize the risk of serious skin reactions.

Q: Does Lidaprim forte have any long-term side effects?

A: Regulatory labeling notes that patients undergoing long-term therapy may require periodic blood count monitoring. This is due to the potential for serious blood disorders, such as Agranulocytosis or Aplastic Anemia, associated with extended use.

Q: Is the medication Lidaprim forte addictive?

A: Lidaprim forte is an antibiotic and is not classified as a controlled substance by regulatory bodies. Therefore, official information indicates it has no known potential for dependence or abuse.

Q: What is the risk of antibiotic resistance with Lidaprim forte?

A: Like all antibiotics, this medicine must only be used to treat bacterial infections proven or strongly suspected to be caused by bacteria. This approach is required to help reduce the development of drug-resistant bacteria and support the continued effectiveness of the medicine.

Q: Can Lidaprim forte be taken if you have diabetes?

A: Official adverse reaction lists note a risk of hypoglycemia (low blood sugar) in patients taking this medication. This risk may be particularly relevant for individuals managing pre-existing conditions like diabetes.

Q: Can I take vitamins or supplements while on Lidaprim forte?

A: Regulatory documents indicate potential interactions with certain supplements. Specifically, supplements containing potassium can raise the risk of hyperkalemia. Furthermore, supplements containing PABA (para-aminobenzoic acid) may interfere with the drug's effectiveness.

Q: What is the recommended approach for the use of Lidaprim forte during pregnancy?

A: Official information states that the drug may cause fetal harm and has been associated with an increased risk of congenital malformations, such as neural tube defects. The medicine should only be used during pregnancy when the potential benefit is determined to justify the potential risk to the fetus.

Q: What is the recommendation for using Lidaprim forte while breastfeeding?

A: The active components of this medicine are excreted into human milk. Regulatory documents generally recommend avoiding breastfeeding during the course of treatment due to the potential for serious adverse reactions, such as bilirubin displacement, in the nursing infant.

Q: What happens if I take too much Lidaprim forte?

A: Acute overdosage symptoms may include loss of appetite, vomiting, fever, blood in urine, confusion, or unconsciousness. Official drug warnings emphasize that seeking emergency medical assistance is necessary in the event of a suspected overdose.

Q: Does Lidaprim forte contain sulfa?

A: Yes, it contains Sulfametrole, which is a member of the sulfonamide, or 'sulfa,' class of antibiotics. Patients with known hypersensitivity to sulfonamides are typically contraindicated from using this medicine.

Q: Can Lidaprim forte interact with blood thinners?

A: Yes, official drug interaction information indicates that this medicine can potentiate the effects of certain blood thinners, such as Warfarin. The combination may necessitate careful monitoring of anticoagulation status.

Q: Can Lidaprim forte be taken with food?

A: The medication is typically well absorbed whether it is taken with or without food. Some regulatory documents suggest that taking the dose with food may help minimize common gastrointestinal side effects, such as nausea or an upset stomach.

Q: Is it normal to feel nauseous when taking Lidaprim forte?

A: Nausea is listed among the most common adverse reactions in regulatory documents, occurring in 1% to 10% of patients. Because of this common classification, experiencing nausea while taking the medicine is a frequently reported occurrence.

Advertisements

How should Lidaprim forte be stored and disposed of?

How to Store and Dispose of Lidaprim forte?

Official regulatory guidelines define specific requirements for the storage and final disposal of Lidaprim forte tablets.


Storage Conditions

Condition Type Requirement
Temperature Store at controlled room temperature (avoid high temperatures).
Environment Keep away from moisture, excessive heat, and light.
Prohibited Do not refrigerate or freeze the tablets.
Security Keep the medicine out of the sight and reach of children and pets.

Storage requires keeping the tablets in a tightly closed container to ensure protection from environmental factors and maintain chemical integrity. The mandatory child-safety requirement prohibits storing the drug in an unsecured location.


Official Disposal

When disposing of unused or expired Lidaprim forte, the regulatory preference is to use an authorized drug take-back program. If a take-back site is unavailable, the tablets can be discarded in household trash after being mixed with an unappealing substance, such as dirt or used coffee grounds, and sealed in a plastic bag. It is strictly prohibited to flush the medication down the toilet or pour it into a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lidaprim forte found in:

A-Z Index: